Use of Maternal Race and Weight Provides Equitable Performance in Serum Screening for Open Neural Tube Defects.
Geralyn M Lambert-MesserlianSydney Webb StricklandJordan WillburChristine VaughanShelby KoenigTaylor WrightGlenn E PalomakiPublished in: Clinical chemistry (2024)
These data show that the historical method of accounting for maternal race and weight in prenatal screening for ONTD provides equitable performance. Using a race-agnostic methodology results in an increased screen-positive rate and a disproportionate rate of required follow-up care for individuals who self-identify as Black.